Evaluation of Balachurna orally and Pichu with Balataila in the management of female infertility

Clinical Management of Vandhyatwa with Balachurna Orally and Pichu with Bala taila WSR to Immunological factors

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/01/006570

Enrollment

120

Registered

2016-01-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Infertility

Interventions

Intervention1: balachurna with balatailapichu: balachurna orally 2gms with balatailapichu Intervention2: balachurnam: oral intake of balachurnam 2gms twice daily for 3 months Intervention3: balathaila

Eligibility

Inclusion criteria

Inclusion criteria: Presence of Antibodies in Cervical mucus and immunological factors

Exclusion criteria

Exclusion criteria: anovulatory cycles, tubal blocks, uterine and peritoneal factors , patients with hiv and aids

Design outcomes

Primary

Measure	Time frame
Assessment of conceptionTimepoint: 3 months for assessment of patients. 3 -5 years for total research	—

Secondary

Measure	Time frame
Assessment of presence of antibodies in the cervical mucus and serumTimepoint: 3 months for assessment of patients. 3 -5 years for total research	—

Countries

India

Contacts

Public ContactLakshmi Maseedu

Health,Medical and Family Welfare

vijaya3107@gmail.com9885313302

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026